High Tide Inc (HITI)vsScienture Holdings, Inc. (SCNX)
HITI
High Tide Inc
$2.39
-1.65%
HEALTHCARE · Cap: $201.29M
SCNX
Scienture Holdings, Inc.
$0.36
-5.26%
HEALTHCARE · Cap: $14.33M
Smart Verdict
WallStSmart Research — data-driven comparison
High Tide Inc generates 131757% more annual revenue ($629.85M vs $477,680). SCNX leads profitability with a 0.0% profit margin vs -7.4%. SCNX earns a higher WallStSmart Score of 33/100 (F).
HITI
Avoid30
out of 100
Grade: F
SCNX
Avoid33
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for HITI.
Margin of Safety
+21.4%
Fair Value
$0.57
Current Price
$0.36
$0.21 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 25.2% year-over-year
Reasonable price relative to book value
Revenue surging 449.1% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
Smaller company, higher risk/reward
Operating margin of 2.3%
Elevated debt levels
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -0.1% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : HITI
The strongest argument for HITI centers on Revenue Growth. Revenue growth of 25.2% demonstrates continued momentum.
Bull Case : SCNX
The strongest argument for SCNX centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 449.1% demonstrates continued momentum.
Bear Case : HITI
The primary concerns for HITI are Market Cap, Operating Margin, Debt/Equity.
Bear Case : SCNX
The primary concerns for SCNX are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
HITI profiles as a growth stock while SCNX is a hypergrowth play — different risk/reward profiles.
SCNX is growing revenue faster at 449.1% — sustainability is the question.
HITI generates stronger free cash flow (3M), providing more financial flexibility.
Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
SCNX scores higher overall (33/100 vs 30/100) and 449.1% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
High Tide Inc
HEALTHCARE · PHARMACEUTICAL RETAILERS · USA
High Tide Inc. is a vertically integrated company in the cannabis market in Canada, the United States and internationally. The company is headquartered in Calgary, Canada.
Visit Website →Scienture Holdings, Inc.
HEALTHCARE · PHARMACEUTICAL RETAILERS · USA
Scienture Holdings, Inc. (SCNX) is a biotechnology firm focused on developing advanced therapeutic solutions for neurological disorders, utilizing an innovative drug development pipeline backed by a skilled research team. With a strong emphasis on addressing unmet medical needs, Scienture is poised to enhance patient outcomes while navigating the complexities of regulatory pathways. The company’s dedication to scientific rigor and its strategic partnerships not only bolster its growth potential but also position SCNX as a significant contributor to advancements in global healthcare. As the demand for effective neurological treatments grows, Scienture aims to leverage emerging opportunities within the expanding healthcare landscape.
Compare with Other PHARMACEUTICAL RETAILERS Stocks
Want to dig deeper into these stocks?